Next Article in Journal
High Cytoplasmic Expression of Krüppel-like Factor 4 Is an Independent Prognostic Factor of Better Survival in Hepatocellular Carcinoma
Next Article in Special Issue
MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics
Previous Article in Journal
Ginsenoside Rd Attenuates Mitochondrial Permeability Transition and Cytochrome c Release in Isolated Spinal Cord Mitochondria: Involvement of Kinase-Mediated Pathways
Previous Article in Special Issue
Gamma Knife Treatment of Brainstem Metastases
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2014, 15(6), 9878-9893; doi:10.3390/ijms15069878

SPECT and PET Serve as Molecular Imaging Techniques and in Vivo Biomarkers for Brain Metastases

1
Section of Nuclear Medicine and Health Physics, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia 06100, Italy
2
Section of Nuclear Medicine, Department of Clinical and Experimental Medicine, University of Sassari, Sassari 07100, Italy
3
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma 00133, Italy
4
IRCCS Neuromed Pozzilli, Pozzilli (Isernia) 86077, Italy
5
Department of Engineering, University of Perugia, Perugia 06100, Italy
6
Section of Radiotherapy Department of Surgical and Biomedical Sciences, University of Perugia, Perugia 06100, Italy
*
Author to whom correspondence should be addressed.
Received: 30 March 2014 / Revised: 13 May 2014 / Accepted: 14 May 2014 / Published: 3 June 2014
(This article belongs to the Special Issue Brain Metastasis 2014)
View Full-Text   |   Download PDF [432 KB, uploaded 19 June 2014]   |  

Abstract

Nuclear medicine techniques (single photon emission computerized tomography, SPECT, and positron emission tomography, PET) represent molecular imaging tools, able to provide in vivo biomarkers of different diseases. To investigate brain tumours and metastases many different radiopharmaceuticals imaged by SPECT and PET can be used. In this review the main and most promising radiopharmaceuticals available to detect brain metastases are reported. Furthermore the diagnostic contribution of the combination of SPECT and PET data with radiological findings (magnetic resonance imaging, MRI) is discussed. View Full-Text
Keywords: brain metastases; molecular imaging; PET; SPECT; MRI; fusion imaging brain metastases; molecular imaging; PET; SPECT; MRI; fusion imaging
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Palumbo, B.; Buresta, T.; Nuvoli, S.; Spanu, A.; Schillaci, O.; Fravolini, M.L.; Palumbo, I. SPECT and PET Serve as Molecular Imaging Techniques and in Vivo Biomarkers for Brain Metastases. Int. J. Mol. Sci. 2014, 15, 9878-9893.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top